McKinney, Texas | Dedicated Research Center

Tekton’s McKinney, TX research site is a dedicated, physician-led research center focused on advancing cardiometabolic clinical trials. Led by Pablo Mora, MD, Tekton’s Cardiometabolic Research Lead, the site is also partnered with actively practicing physicians in the community, including Muhammad Siddiqui, MD of Texas Associates of Endocrinology & Diabetes, P.A.– bringing together specialized research infrastructure with real-world patient care.

This location conducts clinical studies for a broad range of investigational treatments, with a strong focus on cardiometabolic conditions. Trials at this site include:

CKD & T2DM
CKD Stages 1-5
T1D
T2D
Graves Disease
Hyper/hypothyroid
Hypertension
MASH/NASH
Obesity
Peripheral Neuropathy (Diabetic)
Thyroid Eye Disease

Expanded site capabilities include advanced continuous glucose monitoring (CGM) / glucose sensor testing and Automated Insulin Delivery (AID) systems for both type 1 and type 2 diabetes–supported by a dedicated research infrastructure that includes 2 exam rooms, 3 Registered Dietitians and Certified Diabetes Educators, 1 sub-investigator, and a database of over 7,000 participants–enabling a comprehensive, patient-centered approach to research and care.

For more information about joining a study in McKinney, complete the form on this page.

Find a Study in McKinney

Meet Our McKinney Research Team

Contact Us

Office Phone: (972) 777-6011

Find a clinical trial in McKinney
Browse open studies below, then apply online, or call (469) 963-1012.

Get Directions

Tekton Research McKinney
4201 Medical Center Drive, Suite 250, McKinney, TX 75069

Meet Our McKinney Research Team

Our dedicated research team in McKinney brings extensive experience across all phases of clinical research and multiple therapeutic areas, combining scientific expertise with a genuine commitment to advancing patient care.

Every clinical trial at Tekton Research is led by a board-certified Principal Investigator who safeguards participants' rights, safety, and welfare. Our entire research team receives comprehensive training in clinical research regulations, including GCP and HIPAA standards.

Pablo Mora, MD, FACE, MSc, CDCES

Dr. Pablo F. Mora is a renowned Diabetes, Metabolism & Endocrinology KOL (Key Opinion Leader) with 30 years of experience in cardiometabolic care. He specializes in Type 1 Diabetes with emphasis on new insulin delivery methods and the use of modern technology for monitoring and making therapeutic decisions. Dr. Mora serves as a Clinical Professor at University of Texas Southwestern Medical Center’s Division of Endocrinology and has received several prestigious recognitions for his contributions to the field, including the Daniel Foster Award for Clinical Teaching by the Division of Endocrinology at UT Southwestern Medical Center.

Muhammad Siddiqui, MD

Dr. Muhammad Siddiqui is a board-certified endocrinologist with over 18 years of experience in cardiometabolic care and a strong track record in clinical research, having conducted 12 trials to date. A former Chief Fellow at UT Southwestern Medical Center, he now practices in McKinney, Texas, where he is affiliated with Medical City McKinney Hospital. Dr. Siddiqui brings deep clinical expertise and a patient-centered approach to advancing endocrine research, particularly in the areas of diabetes and metabolic disorders.